Cathay Biotech Inc. (SHA:688065)

Cathay Biotech Revenue

Cathay Biotech had revenue of 874.53M CNY in the quarter ending March 31, 2026, with 12.73% growth. This brings the company's revenue in the last twelve months to 3.39B, up 11.30% year-over-year. In the year 2025, Cathay Biotech had annual revenue of 3.30B with 11.40% growth.

• Revenue (ttm): 3.39B
• Revenue Growth: +11.30%
• P/S Ratio: 9.23
• Revenue / Employee: 1.93M
• Employees: 1,761
• Market Cap: 31.32B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.30B	337.14M	11.40%
Dec 31, 2024	2.96B	843.74M	39.91%
Dec 31, 2023	2.11B	-326.93M	-13.39%
Dec 31, 2022	2.44B	77.62M	3.28%
Dec 31, 2021	2.36B	866.29M	57.86%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 21, 2026

Data Sources Report a data error